{"schema_version":"secwatch.filing_event.v1","accession":"0001606498-23-000071","form_type":"8-K","ticker":"AVNS","cik":"0001606498","company_name":"AVANOS MEDICAL, INC.","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.757533+00:00","generated_at":"2026-06-10T06:22:27.876350+00:00","sec_items":["2.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Avanos closes sale of Respiratory Health business to SunMed for $110M cash","bullets":["Divestiture of Avanos' Respiratory Health business closed Oct 2, 2023; $110M cash purchase price subject to adjustments for indebtedness, inventory, and chargebacks.","Amendment adds Assumed Chargeback Liabilities definition; purchase price reduced by estimated chargeback amount with final adjustment by Oct 31, 2023.","India-related assets transferred separately at $910,000 purchase price; India purchase agreement to be executed post-closing.","Indemnification cap for India VAT losses set at $172,000; other amendments modify purchase price calculation and escrow details."],"urls":{"canonical":"https://secwatch.observer/filing/0001606498-23-000071","json":"https://secwatch.observer/filing/0001606498-23-000071.json","markdown":"https://secwatch.observer/filing/0001606498-23-000071.md","text":"https://secwatch.observer/filing/0001606498-23-000071.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/0001606498-23-000071-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/avns-20231002.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:22:27.876350+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"213e4a4806271a741ca5463032d909de86f92956","claim":"AVANOS MEDICAL, INC. completed a disposition involving SunMed Group Holdings, LLC for $110 million in cash (closed 2023-10-02).","evidence_excerpt":"Health (“RH”) business (the “Divestiture”). In accordance with the Amended Purchase Agreement, the total purchase price paid by Buyer in connection with the Divestiture was $110 million in cash at the closing, subject to certain adjustments as provided in the Amended Purchase Agreement based on the indebtedness and inventory transferred to Buyer at the closing","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1606498/000160649823000071/0001606498-23-000071-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"SunMed Group Holdings, LLC"},{"label":"Consideration","value":"$110 million in cash"},{"label":"Closing","value":"2023-10-02"}],"fact_type":"ma_transaction"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}